HEALTHCARE 2.0

Remote disease management and virtual care reimagined

AI

SCIENCE

AI-powered digital health

Phyla has developed an algorithm that can accurately diagnose inflammatory bowel disease using the stool microbiome along with a digital health app for remote IBD/IBS patient management.

 

As we await regulatory approval, Phyla’s algorithm has been repurposed to provide an indicator of the individual’s intestinal health.

 

Instead of a diagnosis, we provide a wellness score which will indicate the level of intestinal microbial disorder as a proxy for an individual’s current disease severity.

REMOTE CARE DELIVERY

Efficient longitudinal monitoring

Phyla provides insight into patients’ lifestyle and regular snapshots of their intestinal health. 

 

Patients can track months of symptom and lifestyle data in between medical appointments and share this with their physicians in an easily digestible format.

 

The at-home, low-cost and accurate nature of Phyla’s  microbiome testing decreases the need for in-person medical visits, diminishes the burden on the healthcare system and lowers stress levels for patients.

Emotional
Well-Being
Mental Clarity
Sleep Cycles
Food

AI

Medication
Your Symptoms
Gut Microbiome Composition
microbiome.gif

DATA-DRIVEN DISEASE MANAGEMENT

Predictive & Personalized Care 

Phyla provides alerts when several serious symptoms are detected by the algorithm. 

 

The relevant information obtained from our approach helps people track treatment adherence and response. 

 

Through Phyla's longitudinal testing and tracking, physicians will be able to care for their patients in a more complete manner, resulting in improved disease management and disease state.

CURRENT RESEARCH COLLABORATIONS

MUHC IBD clinic:

To further validate the accuracy of our algorithms, we are completing a government funded study in Montreal in 2021, with 250 participants at the McGill University Health Center.


CHUSJ:

We have been invited as ‘Innovation Fellows in Residence’ by the St. Justine Mother and Child University Hospital Center to deploy our app to their IBD patients transitioning from pediatric to adult care.

Capture d’écran, le 2020-10-21 à 09.36
Capture d’écran, le 2020-10-21 à 09.42

Get in touch with our Medical Team

Our team of medical experts led by Dr. Houman Farzin are here to answer all your questions. Reach out to chat with us about our solution and the literature behind our science.

Houman_edited.jpg

Dr. Houman Farzin  MD, MSc. Chief Medical Officer

Sani_edited.jpg

Dr. Sani Karam MD, MPH
Chief Medical Product Officer

Kam_edited.jpg

Dr. Kam Kafi MD
Medical AI Expert